To some, the line dividing non-drug form drug products is vague and seemingly unreadable. Most companies go out of their way not to cross the line, in the hopes of not having to deal with the regulatory issues that come with marketing drug products. Yet, more and more often, as new claims come onto the market, the exact point at which your product becomes a drug and not a cosmetic comes into the picture as a critical consideration in product development and marketing.
Establishing the Dividing Line: Is Your Product a Drug?
November 4, 2011
Fill out my online form.
Innovative prebiotic fiber with cross action activities - download studies data [sample request] — Jojoba Desert
Shin-Etsu’s Natural Diluent System Balances Natural Origin and Performance — Shin Etsu Silicones Of America
Most Popular in Claims/Labeling
- 1Unilever’s TRESemmé Shampoo Alleged to Cause Irritation, Hair Loss
- 2False Ad Suit Against CVS Hand Sanitizer Gains Ground
- 3ASTM Int. Proposes Standard for Carbon Intensity Labeling
- 4FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 5Concerns Over Charcoal Safety Raised in Crest Toothpaste Lawsuit
- 6Report: Hand Sanitizer Demand May Lead to Child Labor
- 7ECHA Seeks Comments on Benzisothiazolinone Labeling
- 8Microbiome Claims: Should Pre-, Pro- and Postbiotic Skin Care Be Regulated?
- 9Net Contents of a Cosmetic: The ‘E’ Mark and Units of Measure
- 10Big Win for Cosmetics: Court Closes Prop 65 Titanium Dioxide Case
- FDA Warning Expands: More Hand Sanitizer Recalls Due to Methanol
7/7/2020, Michele Behrens
- USDA Certifies Locus PI Sophorolipids as 100% Bio-based
4/30/2021, Michele Behrens
- Concerns Over Charcoal Safety Raised in Crest Toothpaste Lawsuit
3/19/2021, Rachel Grabenhofer
- Cosmeservice Speeds Cleanser-to-Hand Sanitizer Registration in the EU
5/15/2020, Michele Behrens
- Cradle to Cradle Version 4.0 Certifies 5 Key Sustainability Criteria
3/16/2021, Rachel Grabenhofer